Does ATORVASTATIN Cause Interstitial lung disease? 706 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 706 reports of Interstitial lung disease have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.9% of all adverse event reports for ATORVASTATIN.
706
Reports of Interstitial lung disease with ATORVASTATIN
0.9%
of all ATORVASTATIN reports
123
Deaths
458
Hospitalizations
How Dangerous Is Interstitial lung disease From ATORVASTATIN?
Of the 706 reports, 123 (17.4%) resulted in death, 458 (64.9%) required hospitalization, and 55 (7.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for ATORVASTATIN.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ATORVASTATIN Alternatives Have Lower Interstitial lung disease Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM